Hans-Peter Stoll

Showing 1-8 of 8 articles

Coronary interventions

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H-P, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

September 10, 2019 | 10.4244/EIJ-D-19-00498

Coronary interventions

Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study

Lee WLS, Tam FCC, Chan KKW, Lam S, Kong S-L, Shea CP, Wong MKL, Wong AYT, Yung ASY, Zhang L-W, Lam Y-M, Mintz G, Costa R, Stoll H-P, Maehara A

September 20, 2018 | 10.4244/EIJ-D-18-00061

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H-P, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H-P, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry

Cuculi F, Banning A, Abizaid A, Bartorelli A, Baux A, Dzavik V, Ellis SG, Gao R, Holmes DR, Jeong M, Legrand V, Neumann F, Nyakern M, Spaulding C, Stoll H-P, Worthley S, Urban P

December 30, 2011 | 10.4244/EIJV7I8A152

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

Vaina S, Voudris V, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll H-P, Cokkinos D, Stefanadis C, Serruys P

January 20, 2009

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

Serruys P, Daemen J, Morice M, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll H-P

January 20, 2008

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

Macaya C, Garcia-Garcia H, Colombo A, Morice M, Legrand V, Kuck K, Sheiban I, Suttorp MJ, Carrié D, Vrolix M, Wittebols K, Stoll H-P, Donohoe D, Bressers M, Serruys P

May 20, 2006

1

Latest news

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

NEW ahead of print: Difference of thrombogenicity in durable polymer DES

Representative confocal microscopic images using immunofluorescent staining

Cardiocerebral Continuum in Cognitive Function After TAVI

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Novel Approaches to Guide Revascularization in STEMI & Multivessel CAD

This week's JAA's: BASILICA technique & Intravascular lithotripsy for left main disease

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke